EGFR and lung carcinoma: In recent years, with the rapid development of cancer genomics, it has been confirmed that the occurrence and development of NSCLC are driven by key oncogenes, among which EGFR gene mutation is an important driving factor to induce and maintain lung cancer, especially lung adenocarcinoma10.